These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31516092)

  • 21. [Long-Term Capecitabine Therapy Was Successful for Locally Advanced Breast Cancer Patient - Report of a Case].
    Adachi K; Sakurai K; Suzuki S; Kubota H; Hara Y; Fujiwara A; Enomoto K; Izu A; Sugitani M; Makishima M; Koshinaga T
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):94-96. PubMed ID: 29362319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capecitabine-induced pancreatitis.
    Jones KL; Valero V
    Pharmacotherapy; 2003 Aug; 23(8):1076-8. PubMed ID: 12921254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capecitabine-induced lichenoid drug eruption: a case report.
    Gehlhausen JR; Strausburg MB; Aouthmany M; Katona TM; Turner MJ
    Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of antivirals in the management of neuropathic pain in the older patient with herpes zoster.
    Lilie HM; Wassilew S
    Drugs Aging; 2003; 20(8):561-70. PubMed ID: 12795624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of utidelone plus capecitabine for metastatic breast cancer in China.
    Liao M; Jiang Q; Hu H; Han J; She L; Yao L; Ding D; Huang J
    J Med Econ; 2019 Jun; 22(6):584-592. PubMed ID: 30808230
    [No Abstract]   [Full Text] [Related]  

  • 26. Case report of capecitabine toxicity and use of uridine triacetate.
    Oliver WD; Duffy AP; Hausner PF
    J Oncol Pharm Pract; 2019 Mar; 25(2):470-473. PubMed ID: 28942723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of capecitabine-induced dermatomyositis.
    Saraswat N; Verma R; Neema S; Kumar S
    Indian J Pharmacol; 2018; 50(6):350-353. PubMed ID: 30783329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
    Harbeck N; Saupe S; Jäger E; Schmidt M; Kreienberg R; Müller L; Otremba BJ; Waldenmaier D; Dorn J; Warm M; Scholz M; Untch M; de Wit M; Barinoff J; Lück HJ; Harter P; Augustin D; Harnett P; Beckmann MW; Al-Batran SE;
    Breast Cancer Res Treat; 2017 Jan; 161(1):63-72. PubMed ID: 27798749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible severe fatty liver induced by capecitabine: A case report.
    Jiang Y; He Q; Li S; Shi C; Yang X
    Medicine (Baltimore); 2017 Nov; 96(46):e8547. PubMed ID: 29145260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible Pathways of Capecitabine-Induced Hand-Foot Syndrome.
    Lou Y; Wang Q; Zheng J; Hu H; Liu L; Hong D; Zeng S
    Chem Res Toxicol; 2016 Oct; 29(10):1591-1601. PubMed ID: 27631426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capecitabine-Induced Severe Toxicity Secondary to DPD Deficiency and Successful Treatment with Low Dose 5-Fluorouracil.
    Kodali S; Bathini V; Rava P; Tipirneni E
    J Gastrointest Cancer; 2017 Mar; 48(1):66-69. PubMed ID: 26744322
    [No Abstract]   [Full Text] [Related]  

  • 32. New advances in DPYD genotype and risk of severe toxicity under capecitabine.
    Etienne-Grimaldi MC; Boyer JC; Beroud C; Mbatchi L; van Kuilenburg A; Bobin-Dubigeon C; Thomas F; Chatelut E; Merlin JL; Pinguet F; Ferrand C; Meijer J; Evrard A; Llorca L; Romieu G; Follana P; Bachelot T; Chaigneau L; Pivot X; Dieras V; Largillier R; Mousseau M; Goncalves A; Roché H; Bonneterre J; Servent V; Dohollou N; Château Y; Chamorey E; Desvignes JP; Salgado D; Ferrero JM; Milano G
    PLoS One; 2017; 12(5):e0175998. PubMed ID: 28481884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucositis as a treatment-limiting side effect in the use of capecitabine for the treatment of metastatic breast cancer.
    Bell KA; Perna AG; Hsu S
    J Am Acad Dermatol; 2001 Nov; 45(5):790-1. PubMed ID: 11606938
    [No Abstract]   [Full Text] [Related]  

  • 34. [A case of palmoplantar dysesthesia syndrome caused by capecitabine].
    Elmas ÖF; Metin MS; Kızılyel O; Aktaş A; Birdal C
    Agri; 2016 Jan; 28(1):54-6. PubMed ID: 27225615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eruptive palmoplantar lesions induced by capecitabine: report of a case evaluated with dermoscopy.
    García-Lozano JA; Ocampo-Candiani J; González-Ramírez RA
    Cir Cir; 2019; 87(S1):38-42. PubMed ID: 31501632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between eGFR and capecitabine efficacy/toxicity in metastatic breast cancer.
    Celik E; Samanci NS; Karadag M; Demirci NS; Demirelli FH; Ozguroglu M
    Med Oncol; 2021 Jan; 38(1):11. PubMed ID: 33452614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug interaction between capecitabine and warfarin: a case report and review of the literature.
    Yildirim Y; Ozyilkan O; Akcali Z; Basturk B
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):80-2. PubMed ID: 16502767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
    Masuda N; Lee SJ; Ohtani S; Im YH; Lee ES; Yokota I; Kuroi K; Im SA; Park BW; Kim SB; Yanagita Y; Ohno S; Takao S; Aogi K; Iwata H; Jeong J; Kim A; Park KH; Sasano H; Ohashi Y; Toi M
    N Engl J Med; 2017 Jun; 376(22):2147-2159. PubMed ID: 28564564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation recall myelitis following capecitabine: First case report.
    Guerreiro C; Albuquerque L; Reimão S
    Clin Neurol Neurosurg; 2020 Sep; 196():105978. PubMed ID: 32540712
    [No Abstract]   [Full Text] [Related]  

  • 40. [64-year-old patient with efflorescences on the upper and lower legs].
    Borde JP; Offensperger WB
    Dtsch Med Wochenschr; 2010 Sep; 135(36):1737-8. PubMed ID: 20812158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.